A Study of D3L-001 as Monotherapy in Subjects With HER2-Positive Advanced Solid Tumors
Clinical trial NCT05957536 · RECRUITING
Trial details
- NCT number
- NCT05957536
- Sponsor
- D3 Bio (Wuxi) Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-19
- Primary completion
- 2028-12-19
- Enrollment
- 128
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.